ARGX:NASDAQ
argenx SE - ADR
US$ 930.52
arrow_upward
+1.93%(+17.65) Siku 1
US$ 931.35
arrow_upward
+0.09% (+0.83)bedtimeBaada ya saa
Imefungwa: 6 Okt, 16:00:01 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ARGX...
Fungua
US$ 922.39
Juu
US$ 942.35
Chini
US$ 909.94
Mtaji wa soko
58.45B
Wastani wa kiasi cha mauzo
elfu 255.97
Kiasi cha mauzo ya hisa
3.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
35.35
Juu kwa wiki 52
US$ 1,072.75
Chini kwa wiki 52
US$ 661.85
EPS
US$ 26.32
Beta
0.45
Hisa za wawekezaji
62.56M
Idadi ya wafanyakazi
elfu 2
Fungua
US$ 922.39
Juu
US$ 942.35
Chini
US$ 909.94
Mtaji wa soko
58.45B
Wastani wa kiasi cha mauzo
elfu 255.97
Kiasi cha mauzo ya hisa
3.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
35.35
Juu kwa wiki 52
US$ 1,072.75
Chini kwa wiki 52
US$ 661.85
EPS
US$ 26.32
Beta
0.45
Hisa za wawekezaji
62.56M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
saa 1 iliyopita
Goldman Sachs raises target for Argenx stock to EUR 982.00
Investing.com UK
·
saa 12 zilizopita
Halozyme expands argenx collaboration with two new targets By Investing.com
Stock Titan
·
saa 12 zilizopita
A drug-delivery partnership expands from six exclusive targets to eight.
AD HOC NEWS
·
saa 15 zilizopita
argenx stock: New VYVGART data span myasthenia gravis and CIDP
Wasifu
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Kuhusu argenx SE - ADR
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 1.86
Lilianzishwa25 Apr 2008
Makao makuu-
Sekta-
Tovutiargenx.com